Sagility India Limited
(Formerly Sagility India Private Limited)
Registered Office - No. 23 & 24, AMR Tech Park, Building 2A, First Floor Hongasandara Village, Off Hosur Road, 
Bommanahalli, Bengaluru – 560068 Karnataka India
Corporate Identity Number: U72900KA2021PLC150054
Tel. No.: 080-71251500, Website: www.SagilityHealth.com
Date: February 05, 2025
To, 
The Manager 
Listing Department 
National Stock Exchange (NSE) 
Exchange Plaza, 5th Floor 
Plot No. C/1, G-Block 
Bandra-Kurla Complex 
Bandra (E), Mumbai - 400 051 
Symbol: SAGILITY
To,
The Manager 
Listing Department 
Bombay Stock Exchange (BSE) 
Phiroze Jeejeebhoy Towers 
Dalal Street Mumbai - 400 001 
Scrip Code:544282
Dear Sir/Ma’am, 
Subject: Submission of Investor Presentation to be made to investors on February 05, 2025,
pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and 
Disclosure Requirements) Regulations, 2015
In continuation to our letter dated January 31, 2025, we are enclosing herewith the presentation to be 
made to Investors on the Financial Results of Sagility India Limited for the quarter ended December 31, 
2024, scheduled today i.e., on Wednesday, 05th December 2025 at 7:00PM (IST).
The details are also being made available on the Company’s website www.sagilityhealth.com 
This is for your kind information and record.
Thanking You, 
For Sagility India Limited 
Satishkumar Sakharayapattana Seetharamaiah   
Company Secretary & Compliance Officer   
M. No: A16008
Encl: a/a

Investor Deck – Q3 FY25
Feb 5, 2025

Safe Harbour
Certain statements in this release concerning Sagility’ future growth prospects may be seen as forwardlooking statements, which involve a number of risks and uncertainties that could cause the actuals to differ 
materially from such statements. Sagility does not undertake to update any such statement that may have 
been made from time to time by or on behalf of the company..
2

Key Highlights
► Revenue in Q3 at ₹14,531 million, grew by ₹1,929 million Y-o-Y 
(corresponding to 15.3% growth Y-o-Y and 14.0% at constant currency)
► Adjusted EBITDA at ₹4,567 million, grew by ₹1,837 million Y-o-Y 
(corresponding to 67.3% growth Y-o-Y )
► Adjusted PAT at ₹2,626 million, grew by ₹ 1,059 million Y-o-Y 
(corresponding to 67.6% growth Y-o-Y )
► Revenue in YTD Dec’24 at ₹ 40,014 million grew by ₹5,311 million 
Y-o-Y (corresponding to 15.3% growth Y-o-Y and 13.9% at 
constant currency)
► Adjusted EBITDA at ₹11,104 million, grew by ₹2,578 million Y-o-Y 
(corresponding to 30.2% growth Y-o-Y )
► Adjusted PAT at ₹5,709 million, grew by ₹1,464 million Y-o-Y 
(corresponding to 34.5% growth Y-o-Y )
► Robust year-on-year growth, largely fueled by our tenured existing clients and logos that we had onboarded the last couple of years.
► Our tech and transformation led services utilizing automation, analytics, and GenAI — has substantially strengthened our client relationships and 
positioned us as a trusted strategic and advisory partner. This shift has been pivotal in driving growth and elevating our market perception amongst 
clients.
► Recent acquisition of BroadPath strengthens Sagility’s position among the top ten largest health plans in the US, while also adding 30+ mid-market 
clients to our portfolio
► Operations remain robust, driven by strong performance across key metrics
► People: Global headcount stands at 39,595 as of December 2024.
► 1,215 employees added during Q3 FY25 (3.2% Q-o-Q growth in headcount). 
► Attrition low at 21.8%*
Key Business Highlights
* Voluntary attrition considering employees who were employees for more than 90 days (%) on an annualized basis
Q3 FY25 Highlights YTD Dec FY25 Highlights
3

KPIs
*considering employees who were employees for more than 90 days (%) on an annualized basis
KPI Q3 FY25 Q2 FY25 Q3 FY24 Y-o-Y % YTD Dec
FY25
YTD Dec 
FY24 Y-o-Y %
Revenue from Operation 14,531 13,250 12,602 15.3% 40,014 34,704 15.3%
Revenue by Vertical split
By Payer % 89.3% 89.2% 91.1% 89.2% 90.0%
By Provider % 10.7% 10.8% 8.9% 10.8% 10.0%
Growth in revenue from Operation (%) 15.3% 21.1% 17.6% 15.3% 13.4%
Adjusted EBITDA 4,567 3,378 2,730 67.3% 11,104 8,527 30.2%
Adjusted EBITDA % 31.4% 25.5% 21.7% 27.8% 24.6%
Adjusted PAT 2626 1636 1567 67.6% 5,709 4,245 34.5%
Adjusted PAT % 18.1% 12.3% 12.4% 14.3% 12.2%
Total Number of Employees 39,595 38,380 36,639 39,595 36,639 8.1%
Voluntary attrition rate* (%) 21.8% 25.8% 21.2% 24.8% 25.2%
4
Amt in INR M

About BroadPath Healthcare Solutions
► Founded in 2008, headquartered in Tucson, Arizona, US.
► BroadPath is a Healthcare focused services company
► BroadPath services portfolio includes member engagement, 
member acquisition, claims and appeals administration, provider 
enrolment and credentialing.
► Strong portfolio of clients including several mid-market clients 
► Strong NPS amongst the clients. 
► Pioneer in the work-from-home model even before the COVID-19 
pandemic
► Bhive is their proprietary platform designed to enhance 
employee engagement and optimize operational metrics in a 
remote work environment
30+ 
Customers
1,600+ 
employees
US and 
Philippines
Revenues
~$70M+ for CY24 

Increased presence in Top 10 
payers 
Compelling Strategic and Financial rationale
► Add another top 10 US payer to our 
list of clients
► Expand footprint with other two 
existing Top 10 payer clients
► Post-acquisition, serve six Top 10 U.S. 
payers, strengthening our leadership 
in the large payer segment
Diversified Client Base 
► Access to 30+ mid-market clients
► Opportunity to cross-sell broader 
services that Sagility offers.
► Diversifies revenue base across client 
segments
Expanded Capabilities 
► Expand service offerings across the 
Payer value chain with enhanced 
Medicare & Medicaid member 
acquisition and enrolment services
► Sagility’s multi-shore delivery model 
adds significant value to BroadPath 
clients
► Improved efficiency by scaling 
Sagility’s onshore operations.
► Reduced combined administrative 
costs
► Increase sales efficiency and 
resource utilization
Financial Synergies Enhancing Engagement & 
Efficiency with Bhive
► Enhanced productivity with Bhive 
platform
► Integrating Bhive with Sagility’s GenAI 
solutions to drive operational 
efficiencies
Talent Acquisition
► 1600+ employees with strong 
operational expertise in a work-fromhome delivery model
► Strengthen sales, marketing, and 
account management with strong 
market facing team
Acquisition to be EPS accretive from Day one. Funded 100% from Cash. 

Financial Highlights

Highlights
Q3 FY25 Financial Highlights
► Q3 FY25 revenue stood at ₹14,531 Million ($172.0 M)
► 15.3% growth Y-o-Y (14.0% at constant currency )
► 9.7% growth Q-o-Q (9.0% at constant currency)
► Adjusted EBITDA at ₹4,567 Million ($54.1 M) 
► Adjusted EBITDA Margin : 31.4%
► 67.3% growth Y-o-Y; 35.2% growth Q-o-Q
► Includes Other income of ₹440 Million ($5.2 M)
► Adjusted PAT at ₹2,626 Million ($31.1 M)
► Adjusted PAT Margin: 18.1%
► 67.6% growth Y-o-Y; 60.5% growth Q-o-Q
► OCF ₹3,043 Million ($ 36.0 M)
► 69.8% of EBITDA
► YTD Dec FY25 revenue stood at ₹40,014 Million ($476.5 M)
► 15.3% growth Y-o-Y (13.9% at constant currency )
► Adjusted EBITDA at ₹11,104 Million ($132.2 M)
► Adjusted EBITDA Margin : 27.8%
► 30.2% growth Y-o-Y
► Includes Other income of ₹596 Million ($7.1 M) 
► Adjusted PAT at ₹5,709 Million ($68.0 M)
► Adjusted PAT Margin : 14.3 %
► 34.5% growth Y-o-Y
► OCF ₹9,132 Million ($108.7 M)
► 94.0% of EBITDA
Strong Q3 and YTD Dec FY25 Performance
YTD Dec FY25 Financial Highlights
8

₹11.2 ₹10.9
₹12.6 ₹12.8
12.8% 11.5% 12.4% 12.9%
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
30.0%
35.0%
40.0%
₹9.0
₹10.0
₹11.0
₹12.0
₹13.0
₹14.0
₹15.0
Q1 FY24 Q2 FY24 Q3 FY24 Q4 FY24
Revenue INR B Adjusted PAT %
Quarter wise performance
₹12.2
₹13.3
₹14.5
11.8% 12.3%
18.1%
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
30.0%
35.0%
40.0%
₹9.0
₹10.0
₹11.0
₹12.0
₹13.0
₹14.0
₹15.0
Q1 FY25 Q2 FY25 Q3 FY25 Q4 FY25
Revenue INR B Adjusted PAT %
33.5
Q3 FY25 - High PAT driven by higher Other income led by high Forex gain and higher margins during Open enrollment season. 
FY 24 FY 25
36.5 36.6 35.0
35.8 38.3 39.6
Headcount 
(‘000)
Headcount 
(‘000)

Financial performance snapshot – Q3 FY25
Revenue 
(INR Million) 
Y-o-Y Q-o-Q
15.3% 9.7%
Adjusted EBITDA 
(INR Million)
Y-o-Y Q-o-Q
67.3% 35.2%
Adjusted PAT
(INR Million)
Y-o-Y Q-o-Q
67.6% 60.5%
Revenue ($M) 
Y-o-Y Q-o-Q
14.0% 9.0%
Adjusted EBITDA 
($M)
Y-o-Y Q-o-Q
65.8% 34.4%
Adjusted PAT
($M)
Y-o-Y Q-o-Q
66.0% 59.7%
10
₹12,602
₹13,250
₹14,531
Q3'24 Q2'25 Q3'25
₹2,730
₹3,378
₹4,567
Q3'24 Q2'25 Q3'25
₹1,567 ₹1,636
₹2,626
Q3'24 Q2'25 Q3'25
$150.8
$157.9
$172.0
Q3'24 Q2'25 Q3'25
$32.6
$40.3
$54.1
Q3'24 Q2'25 Q3'25
$18.8 $19.5
$31.1
Q3'24 Q2'25 Q3'25

Financial performance snapshot – Long Term
Revenue 
(INR Million) 
FY24 YoY% YTD Dec YoY%
12.7% 15.3%
Adjusted EBITDA 
(INR Million)
FY24 YoY% YTD Dec YoY%
12.1% 30.2%
Adjusted PAT
(INR Million)
FY24 YoY% YTD Dec YoY%
29.4% 34.5%
Revenue ($M) 
FY24 YoY% YTD Dec YoY%
10.5% 13.9%
Adjusted EBITDA 
($M)
FY24 YoY% YTD Dec YoY%
10.0% 28.6%
Adjusted PAT
($M)
FY24 YoY% YTD Dec YoY%
27.0% 32.8%
11
₹42,184
₹47,536
₹34,704
₹40,014
FY'23 FY'24 YTD Dec'23 YTD Dec'24
₹10,449
₹11,715
₹8,527
₹11,104
FY'23 FY'24 YTD Dec'23 YTD Dec'24
₹4,556
₹5,896
₹4,245
₹5,709
FY'23 FY'24 YTD Dec'23 YTD Dec'24
$518.2 $572.9
$418.5 $476.5
FY'23 FY'24 YTD Dec'23 YTD Dec'24
$128.4 $141.2
$102.8
$132.2
FY'23 FY'24 YTD Dec'23 YTD Dec'24
$56.0
$71.1
$51.2
$68.0
FY'23 FY'24 YTD Dec'23 YTD Dec'24

Financial Indicators
Adjusted EPS is Adjusted PAT divided by weighted average number of equity shares
Adjusted ROCE is Adjusted PAT plus Interest cost divided by capital employed (Assets excluding goodwill and intangibles less current liabilities)
Net Debt is Borrowing plus lease liabilities less Cash and Cash equivalent. Borrowing doesn’t include accrued interest 12
1.06 
1.38 
1.63 
FY'23 FY'24 TTM Dec'24
Adjusted EPS (in INR)
82.0% 87.2%
94.0%
68.2% 70.8%
82.5%
FY'23 FY'24 YTD Dec'24
Cash Conversion (%)
OCF % FCF %
₹22,863 ₹21,678
₹7,924
2.19x
1.85x
0.55x
 -
 0.50
 1.00
 1.50
 2.00
 2.50
₹0
₹5,000
₹10,000
₹15,000
₹20,000
₹25,000
FY'23 FY'24 TTM Dec'24
Net Debt
Net Debt (in INR Million) Net Debt to Adjusted EBITDA
41.6%
47.0% 45.7%
FY'23 FY'24 TTM Dec'24
Adjusted ROCE %

Q3 & YTD Dec FY25 Consolidated Financials 
Amt in INR M
Particulars Q3 FY25 Q2 FY25 Q3 FY24 YoY% QoQ% YTD Dec 
FY25
YTD Dec 
FY24 YoY%
Revenue from Operation 14,531 13,250 12,602 15.3% 9.7% 40,014 34,704 15.3%
Other Income 440 153 57 596 234 
Employee benefits expense 8,620 8,124 7,983 25,248 21,382 
Other expenses 1,988 2,115 2,017 5,652 5,514 
Reported EBITDA 4,362 3,165 2,659 64.1% 37.8% 9,710 8,042 20.7%
Adjusted EBITDA 4,567 3,378 2,730 67.3% 35.2% 11,104 8,527 30.2%
Adjusted EBITDA % 31.4% 25.5% 21.7% 27.8% 24.6%
Adjusted EBITDA excl. other income 4,127 3,224 2,673 54.4% 28.0% 10,508 8,293 26.7%
Adjusted EBITDA excl. other income % 28.4% 24.3% 21.2% 26.3% 23.9%
Finance costs 302 297 468 973 1,422 
Depreciation and amortisation expenses 1,162 1,264 1,756 3,525 5,132 
Profit Before Tax 2,898 1,604 435 565.9% 80.7% 5,212 1,488 250.3%
Tax Expenses 729 431 (271) 1,647 7
Reported Profit After Tax 2,169 1,173 706 207.3% 84.9% 3,565 1,481 140.8%
Adjusted PAT 2,626 1,636 1,567 67.6% 60.5% 5,709 4,245 34.5%
Adjusted PAT % 18.1% 12.3% 12.4% 14.3% 12.2%
Adjusted EPS (Basic and Diluted) (Rs) 0.56 0.35 0.37 53.5% 60.5% 1.24 0.99 25.4%
* Financials for YTD Dec FY25, Q3 FY25, Q2 FY25 and Q3 FY24 are unaudited
13

Adjustments on EBITDA and PAT
Adj EBITDA Bridge: Q3 FY25 Adj EBITDA Bridge: YTD Dec FY25
Adj A - Earnouts under acquisition agreements and for PAT it is adjusted for tax
Adj B - Share based payment awards and for PAT it is adjusted for tax
Adj C - Intangible assets Amortization is amortization of intangible assets acquired pursuant to business combinations and for PAT it is adjusted of tax
Adj PAT Bridge: Q3 FY25 Adj PAT Bridge: YTD Dec FY25
INR Million
INR Million INR Million
INR Million
14
₹4,362 ₹120 ₹85 ₹4,567
Reported EBITDA Adj A Adj B Adjusted EBITDA
₹9,710 ₹364
₹1,030 ₹11,104
Reported EBITDA Adj A Adj B Adjusted EBITDA
₹2,169 ₹88 ₹85
₹284 ₹2,626
Reported PAT Adj A Adj B Adj C Adjusted PAT
₹3,565 ₹267
₹1,030
₹847 ₹5,709
Reported PAT Adj A Adj B Adj C Adjusted PAT

Go Forward Positions
* Numbers are based on the current visibility of management and are subject to change. Factors such as new loans, acquisitions, foreign exchange rate or changes in our share-based payment 
award plan could impact the final figures
15
Amount in INR M
Particulars FY'25 FY'26 FY'27 FY'28 FY'29
Closing Debt position 8,020 5,670 
Debt Repayment 2,490 2,350 5,670 
Interest Payment 746 535 285 
Share based Payment awards 1,089 218 133 72 35 
Earnouts Cost - DCI / Birch 486 348 
Intangibles Amortisation 1,396 1,416 1,416 1,416 1,416 

Balance Sheet as on 31st Dec’24 
Financials for Dec’24 are unaudited. Financials for Mar’24 are Audited 16
Amt in INR M
Particulars Dec'24 Mar'24
Property, plant and equipment 3,636 3,832
Capital-work-in-progress
0 57
Right-of-use assets 5,609 5,665
Goodwill 57,731 57,096
Other intangible assets 19,369 20,078
Trade receivables 11,452 11,813
Cash and cash equivalents 7,263 3,441
Deferred tax assets (net) 1,380 1,354
Other Assets 2,815 3,305
Total Assets 109,254 106,642
Equity 81,110 64,431
Borrowings 9,324 19,335
Lease liabilities 5,922 5,982
Trade payables 2,173 2,593
Other financial liabilities 2,585 6,587
Deferred tax liabilities (net) 4,461 4,710
Other Liabilities 3,678 3,004
Total Liabilities 109,254 106,642

Cash Flow – YTD Dec FY25 
17
• Financials for YTD Dec FY’25 are unaudited. Financials for FY’24 are Audited
• Others in investing activities include Proceeds from sale of property, plant and equipment and other intangible assets and Proceeds from maturity of 
derivative assets/liabilities, (net) and Interest received
Amt in INR M
Particulars YTD Dec FY25 FY'24
Profit before tax for the period/ year 5,212 2,417
Adjustment for Non-Operating and Non-Cash 5,394 8,693
Adjustment for working capital (470) (114)
Income taxes paid (net of refunds) (1,005) (1,263)
Net cash flows generated from operating activities (A) - OCF 9,132 9,733
Acquisition of property, plant and equipment and other intangible assets (1,122) (1,827)
Free Cash flow (FCF) 8,009 7,905
Payment for business combination, net of cash acquired (3,786) (3,010)
Others 299 147
Net cash flows (used in) investing activities (B) (4,609) (4,691)
Proceeds from issue of shares by subsidiaries in a related party transaction 3,708 0
Share issue expense (paid)/ reimbursed 72 (72)
Repayment of borrowings and lease liabilities (3,501) (5,546)
Interest paid on borrowings and lease liabilities (1,111) (1,896)
Net cash flows (used in) financing activities (C) (832) (7,513)
Net increase/ (decrease) in cash and cash equivalents (A+B+C) 3,691 (2,471)
Cash and cash equivalents at the beginning of the year/period 3,441 5,853
Effect of movement in exchange rates on cash and cash equivalents 131 60
Cash and cash equivalents at the end of the year/ period 7,263 3,441
Net cash flows generated from operating activities % (OCF on EBITDA) 94.0% 87.2%
Free Cash flow % (FCF on EBITDA) 82.5% 70.8%

Thank You